It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
All patients enrolled in OmniSource® have access to a Nurse Trainer who is available to teach them and their caregivers how to safely administer Omnitrope® at home. To arrange access to a Nurse Trainer, be sure to select ‘Injection Training’ on their Statement of Medical Necessity (SMN).
We offer three choices of injection training to suit your patients’ needs – at home, over the telephone or by video chat. Patients can speak to their OmniSource Case Manager (OCM) to arrange their training session. Additional refresher training is also available, if required.
These videos are a useful resource for caregivers - and children - learning to inject Omnitrope at home.
All patients and caregivers who will administer Omnitrope should receive training and instruction on the proper use of Omnitrope. Patients should review the full Prescribing Information and Instructions for Use, and ask their healthcare professional about anything they do not understand.
Highlights of Omnitrope Pen
Reusable design, kinder to the planet
As opposed to disposable pens, the Omnitrope Pen is designed to be friendly on the environment and reusable for up to two years. If your patients have any challenges with their Pen within that time, they may reach out to their OmniSource Case Manager on 877.456.6794 (Monday – Friday, 8 AM – 8 PM ET). An OCM can also coordinate the delivery of a new Pen, when your patient is approaching the end of this two-year period.
Highlights of Omnitrope Vial and Syringe
Help your patients make a great start on their growth journey by enrolling them in OmniSource.
The OmniSource team provides personalized support services to help your patients each step of the way.
We’re committed to serving a wide variety of patients prescribed growth hormone.
Personalized support, each step of the way. Click here to enroll your patient.
Omnitrope® is a recombinant human growth hormone indicated for:
Please see full Prescribing Information for Omnitrope.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch